Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Return on Equity %

Amag Pharmaceuticals Return on Equity % Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Return on Equity % from 2010 to 2020.
  • Amag Pharmaceuticals Return on Equity % for the quarter ending June 06, 2020 was -20.65 a 6.66% decrease of -1.37 year over year
  • Amag Pharmaceuticals Return on Equity % for the last 12 months ending June 06, 2020 was -69.13 a 32.98% decrease of -22.80 year over year
  • Amag Pharmaceuticals Annual Return on Equity % for 2019 was -91.57 a 75.47% decrease of -69.11 from 2018
  • Amag Pharmaceuticals Annual Return on Equity % for 2018 was -22.47 a -6.68% increase of 1.50 from 2017
  • Amag Pharmaceuticals Annual Return on Equity % for 2017 was -23.97 a 100.94% decrease of -24.19 from 2016
Other Margins & Efficiency Metrics:
  • Amag Pharmaceuticals EBITDA Margin for the quarter ending December 12, 2018 was $0m a -26,297.24% decrease of -25m year over year
  • Amag Pharmaceuticals Return on Capital % for the quarter ending September 09, 2018 was -1.36 a 8.15% decrease of -0.11 year over year
View Chart On Koyfin

Quarterly AMAG Return on Equity % Data

06/2020-20.65
03/2020-33.04
12/2019-211.60
09/2019-19.28
06/2019-87.00
03/2019-71.74
12/2018-12.49
09/2018-34.75
06/2018-14.08
03/2018-30.37

Annual AMAG Return on Equity % Data

2019-91.57
2018-22.47
2017-23.97
20160.22
20154.71
201442.96
2013-5.56
2012-9.48
2011-36.19
2010-41.80